Skip to content

Subtenon block for paediatric glaucoma surgery.

SUB TENON BLOCK AS AN ALTERNATIVE TO INTRAVENOUS FENTANYL FOR PEDIATRIC GLAUCOMA SURGERY: A RANDOMISED CONTROLLED TRIAL - -

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020759
Enrollment
70
Registered
2019-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H402- Primary angle-closure glaucoma

Interventions

Intervention1: Sub tenon block: patients in this group will receive equivalent volume (0.2 ml/kg) normal saline intravenously and simultaneous subtenon block with 0.08-0.1ml/kg of 2% lignocaine and 0.

Sponsors

PGIMER Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Babies with primary congenital glaucoma of upto 2 years age who require glaucoma surgery in form of combined trabeculotomy with trabeculectomy will be included.

Exclusion criteria

Exclusion criteria: Children whose parents were unwilling to give consent; (ii) Children with full stomach (iii) Children with a history of allergy to local anaesthetics or opioids (iv) Children scleral pathology/ scarring (v) Children with endophthalmitis or inflammatory eye pathology. (vi) One eyed patient.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be to determine whether subtenon block would provide adequate perioperative analgesia during the 24-hr study period (determined by the number of children requiring rescue analgesia during the 24-hr study period in the subtenon block group.)Timepoint: 30 min, 1 hour, 2 hour, 4 hour, 8 hour, 24 hour

Secondary

MeasureTime frame
The secondary outcome measures will be pain scores, time to first rescue analgesia, frequency of rescue analgesia (number of rescues required), incidence of oculo-cardiac reflex, chemosis and subconjunctival haemorrhage, sedation scores and incidence of nausea/vomiting.Timepoint: 30 min, 1 hour, 2 hour, 4 hour, 8 hour, 24 hour

Countries

India

Contacts

Public ContactDr Neeti Dogra

Post Graduate Institute of Medical Education and Research

neeti_dogra@rediffmail.com8708101089

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026